1q21.1 duplication syndrome

From WikiMD's WELLNESSPEDIA

A genetic disorder caused by duplication of a region on chromosome 1

1q21.1 duplication syndrome
Synonyms 1q21.1 microduplication
Pronounce N/A
Specialty N/A
Symptoms Developmental delay, intellectual disability, autism spectrum disorder, congenital heart defects, schizophrenia
Complications N/A
Onset Congenital
Duration Lifelong
Types N/A
Causes Genetic mutation
Risks Family history
Diagnosis Genetic testing, chromosomal microarray analysis
Differential diagnosis 1q21.1 deletion syndrome, other chromosomal abnormalities
Prevention N/A
Treatment Supportive care, special education, therapy
Medication N/A
Prognosis Variable
Frequency 1 in 3,000 to 1 in 5,000
Deaths N/A


1q21.1 duplication syndrome

1q21.1 duplication syndrome is a genetic disorder caused by the duplication of a small region on the long arm of chromosome 1. This condition is associated with a variety of clinical features, which can vary widely among affected individuals.

Genetics[edit]

1q21.1 duplication syndrome is characterized by the presence of an extra copy of a segment of genetic material on chromosome 1, specifically at the 1q21.1 location. This duplication can be inherited in an autosomal dominant manner, meaning that a single copy of the duplicated region is sufficient to cause the disorder. However, the condition can also occur de novo, meaning it arises spontaneously without being inherited from a parent.

Clinical Features[edit]

The clinical presentation of 1q21.1 duplication syndrome is highly variable. Some individuals with the duplication may be asymptomatic, while others may exhibit a range of symptoms. Common features include:

Diagnosis[edit]

Diagnosis of 1q21.1 duplication syndrome is typically made using genetic testing methods such as chromosomal microarray analysis or fluorescence in situ hybridization (FISH). These tests can identify the presence of the duplicated region on chromosome 1.

Management[edit]

There is no cure for 1q21.1 duplication syndrome, and treatment is generally supportive and symptomatic. Management may involve:

Prognosis[edit]

The prognosis for individuals with 1q21.1 duplication syndrome varies depending on the severity of symptoms and associated conditions. Some individuals may lead relatively normal lives, while others may require ongoing medical and educational support.

Related pages[edit]

This article is a stub related to genetics. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.